3.2K views · 122 reactions | We’re building on our existing relationship with Vir Biotechnology, to include R&D of new therapeutics for influenza and other respiratory viruses. The expanded collaboration will combine both companies’ expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates. https://www.gsk.com/en-gb/ | GSK | Facebook

The best treatment for COVID-19, besides protecting yourself with the vaccine, is a monoclonal antibody infusion. If you think you have COVID-19, get tested sooner rather than later so, if needed, this treatment could be an option for you. Check out this video from Connie Hill explaining the treatment. | St. Bernards Healthcare